Semi-supervised learning for somatic variant calling and peptide identification in personalized cancer immunotherapy

BACKGROUND: Personalized cancer vaccines are emerging as one of the most promising approaches to immunotherapy of advanced cancers. However, only a small proportion of the neoepitopes generated by somatic DNA mutations in cancer cells lead to tumor rejection. Since it is impractical to experimentall...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherafat, Elham, Force, Jordan, Măndoiu, Ion I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772914/
https://www.ncbi.nlm.nih.gov/pubmed/33375939
http://dx.doi.org/10.1186/s12859-020-03813-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772914/
https://www.ncbi.nlm.nih.gov/pubmed/33375939
http://dx.doi.org/10.1186/s12859-020-03813-x

Ejemplares similares